Geriatrics
Update
On site
Online

Date
Tuesday, September 22, 2026
Time
08:00 – 08:45
Duration
45 min
Credits
1 Credit
Language
English
Objectives
- Get a holistic view of the role of bone forming agents in the management of osteoporosis. - Identify the pros and cons of PTH R1 Agonists and anti-sclerostin antibody and select which drug is the most appropriate for which patients.
Provider
Klinik Barmelweid
On site
Online
As a webinar on geriatrics-update.com. We will send you the link by email a few days before the event.
MD, PhD, MPH Jean Yves Reginster,
Co-Director, WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging, Liège, Belgium (BE)
Dear colleagues,
dear friends and supporters of geriatric medicine,
It is my great pleasure to welcome you to the continuation of our Geriatrics Seminar Series. With the 2026 annual program, we once again set new standards — scientifically, didactically, and in terms of content — while continuing our mission to further develop geriatrics as an academically grounded, interdisciplinary, and forward-looking field. Geriatrics operates at the intersection of medicine, technology, and society — and it is precisely here that we aim to build bridges, connecting clinical excellence, research, and education. Geriatrics exemplifies the medicine of the future: complex, interconnected, and profoundly human.
With international participation, innovative formats, and a clear scientific focus, we are creating a space for reflection, exchange, and progress. A major milestone is the new interactive platform geriatrics-update.com — a digital knowledge network that links continuing education, research, and clinical practice. It enables direct dialogue between clinical care, science, and society, and is unique in its form in Switzerland.
The 2026 program reflects the breadth and depth of modern geriatric medicine: from longevity and muscle health to delirium management, digitalization and artificial intelligence, geriatric oncology, empathy, and ethical leadership. These topics mirror the evolution of a discipline that extends far beyond daily clinical work, touching on fundamental questions of quality of life, meaning, and sustainability.
Our aspiration remains unchanged: We combine scientific excellence with compassionate care — and actively shape the future of healthy aging. My heartfelt thanks go to all speakers and participants whose expertise and enthusiasm make the Barmelweid Geriatrics Seminar Series recognized far beyond Switzerland’s borders as a place of learning, encounter, and innovation.
Yours sincerely,
PD Dr. med. Mathias Schlögl,
Chefarzt Geriatrie, Klinik Barmelweid
Jean-Yves Reginster M.D., M.PH. Ph.D. is Emeritus Professor of Epidemiology, Public Health and Health Economics and Emeritus Professor of Bioethics and Societal Medicine at the University of Liège. He is Director of the WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Aging and Professor of Medicine at King Saud University, Riyadh, KSA. He is President of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Co-Founder, Board member and Secretary General of the International Osteoporosis Foundation (IOF).